|
ZNF800 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.340200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.313400E-01 |
| Normal-vs-Stage2 |
5.853200E-01 |
| Normal-vs-Stage3 |
1.940040E-01 |
| Normal-vs-Stage4 |
1.874210E-01 |
| Stage1-vs-Stage2 |
9.378400E-01 |
| Stage1-vs-Stage3 |
7.156600E-01 |
| Stage1-vs-Stage4 |
7.023600E-01 |
| Stage2-vs-Stage3 |
6.996600E-01 |
| Stage2-vs-Stage4 |
7.649600E-01 |
| Stage3-vs-Stage4 |
9.967000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.479000E-01 |
| Normal-vs-AfricanAmerican |
5.748200E-01 |
| Normal-vs-Asian |
3.242000E-01 |
| Caucasian-vs-AfricanAmerican |
6.762200E-01 |
| Caucasian-vs-Asian |
8.960800E-01 |
| AfricanAmerican-vs-Asian |
7.963600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.396150E-01 |
| Normal-vs-Female |
6.738200E-01 |
| Male-vs-Female |
1.190210E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.064400E-01 |
| Normal-vs-Extreme_Weight |
1.085840E-01 |
| Normal-vs-Obese |
4.223400E-01 |
| Normal-vs-Extreme_Obese |
5.405800E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.652400E-01 |
| Normal_Weight-vs-Obese |
5.089800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.681000E-01 |
| Extreme_Weight-vs-Obese |
4.206800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.868000E-01 |
| Obese-vs-Extreme_Obese |
6.471400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.120200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.969000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.205700E-02 |
| Normal-vs-Age(81-100Yrs) |
3.143800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.233800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.696820E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.900800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.665950E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.387200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.910800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.098400E-01 |
| Normal-VS-Type2 PRCC |
1.820500E-02 |
| Normal-VS-KIRP CIMP |
7.151800E-01 |
| Normal-VS-Unclassified PRCC |
6.487800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.529700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.042200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.093200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.999400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.266200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.728400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.795000E-04 |
| Normal-vs-N1 |
4.883000E-01 |
| Normal-vs-N2 |
4.159100E-03 |
| N0-vs-N1 |
6.529800E-02 |
| N0-vs-N2 |
4.990000E-01 |
| N1-vs-N2 |
1.672030E-01 |
|
|
